On August 29, 2024 AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, reported that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its senior management team, are scheduled to participate in multiple upcoming investor conferences (Press release, AnaptysBio, AUG 29, 2024, View Source [SID1234646196]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2024 Wells Fargo Healthcare Conference, Boston, MA

Format – Fireside chat and one-on-one investor meetings
Date and Time – Thursday, Sept. 5, 2024 at 10:15am ET / 7:15am PT

Stifel 2024 Virtual Immunology and Inflammation Summit

Format – Fireside chat
Date and Time – Tuesday, Sept. 17, 2024 at 1:30pm ET / 10:30am PT

2024 Cantor Fitzgerald Global Healthcare Conference, New York, NY

Format – Fireside chat and one-on-one investor meetings
Date and Time – Wednesday, Sept. 18, 2024 at 9:45am ET / 6:45am PT

Live webcasts of the fireside chats will be available on the investor section of the Anaptys website at View Source Replays of the webcasts will be available for at least 30 days following the events.